2CU-11539-67194
3 vaccinations
7 coded responses
29 check-ins
7 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 660 / KS
- Registered
- 2021-02-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-29
Dose 1 — Moderna
-
2021-02-26
Registered in v-safe
-
2021-02-26
Dose 2 — Moderna
- 2021-02-26
- 2021-02-27
-
2021-02-28
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Itching · NoneAdult check-in
-
2021-03-01
Survey response — days 1–6 daily, dose 2MedDRA: Injection site bruising — Feeling: Good · Site: RednessFree text: Bruising at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-02
Survey response — days 1–6 daily, dose 2MedDRA: Injection site bruising — Feeling: Good · Site: RednessFree text: Bruising at infection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-04
- 2021-03-05
- 2021-03-12
- 2021-03-19
- 2021-03-26
- 2021-04-02
- 2021-04-09
-
2021-05-30
Survey response — 3 months, dose 2MedDRA: Blood thyroid stimulating hormone decreased, Immunisation reaction — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: TSH thyroid reading lower & in hyperthyroid range cMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-30
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-08-27
Survey response — 6 months, dose 2MedDRA: Blood thyroid stimulating hormone decreased — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Needed to reduce dosage of sythroid medication due to Unusual drop in blood TSH levels.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-27
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-31
-
2021-10-26
Dose 3 — Moderna
-
2021-10-27
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-10-28
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-10-29
- 2021-10-30
- 2021-10-31
- 2021-11-01
-
2021-11-04
Survey response — day 7, dose 3MedDRA: Dizziness, Headache, Pyrexia — Feeling: GoodFree text: Two days after the booster I felt lightheaded or a few minutes. Not normal at all for me. Other than headache a occasionally feverish, felt normal 4 days after shot.MedDRA releases: 2024-11 · check-in free text available
- 2021-11-11
- 2021-11-16
- 2021-11-24
- 2021-11-30
- 2021-12-07
-
2022-01-25
Survey response — 3 months, dose 3MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Covid-19MedDRA releases: 2024-11 · check-in free text available
-
2022-01-25
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2022-01-26
-
2022-04-26
Survey response — 6 months, dose 3MedDRA: Post-acute COVID-19 syndrome, SARS-CoV-2 test positive — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Tested positive for Covid 19 in December, 2 months after booster vaccine. Currently experiencing long Covid symptoms.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-26
Report sent to call center — 6 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2022-04-27
- 2022-10-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-29 | Moderna | |
| 2 | 2021-02-26 | Moderna | |
| 3 | 2021-10-26 | Moderna | No |
Call center
4 call center cases
4 unsuccessful
Free text
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Bruising at injection site
Systemic reaction (other): Bruising at infection site
Release 8 — 3 months, dose 2
Symptoms: TSH thyroid reading lower & in hyperthyroid range c
Release 9 — 6 months, dose 2
Symptoms: Needed to reduce dosage of sythroid medication due to Unusual drop in blood TSH levels.
Release 10 — day 7, dose 3
Systemic reaction (other): Two days after the booster I felt lightheaded or a few minutes. Not normal at all for me. Other than headache a occasionally feverish, felt normal 4 days after shot.
Release 11 — 3 months, dose 3
Symptoms: Covid-19
Release 11 — 6 months, dose 3
Symptoms: Tested positive for Covid 19 in December, 2 months after booster vaccine. Currently experiencing long Covid symptoms.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Blood thyroid stimulating hormone decreased | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Immunisation reaction | ✓ | ✓ | ✓ |
| SD | Post-acute COVID-19 syndrome | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | Dizziness | · | · | ✓ |
| SRO | Headache | · | · | ✓ |
| SRO | Injection site bruising | ✓ | ✓ | ✓ |
| SRO | Pyrexia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release